Showing results (71-80 of 225) with videos related to
Sort By:
Pageof 23
Klinische Wochenschrift|January 4, 1990
Class differentiation of immunoglobulin-containing cerebrospinal fluid cells in inflammatory diseases of the central nervous systemP Rieckmann, T Weber, K FelgenhauerAnnals of Neurology|December 16, 1998
Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseasesH Tumani, R Nau, K FelgenhauerKlinische Wochenschrift|March 16, 1987
Evidence for different immune responses to HIV in CSF and serum?T Weber, W Büttner, K FelgenhauerAnnals of Neurology|June 18, 1998
Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJDR G Will, A Alperovitch, S Poser, et al.Acta Neurologica Scandinavica|September 15, 2000
Creutzfeldt-Jakob disease and oxidative stressS Bleich, S Kropp, D Degner, et al.Journal of Neurology|July 1, 1992
Specific antigen binding by activated cerebrospinal fluid B lymphocytes in acute neuroborreliosisW Beuche, A Siever, K FelgenhauerKlinische Wochenschrift|November 15, 1982
Low molecular solutes and the blood cerebrospinal fluid barrierK Felgenhauer, N Liappis, M NekicJournal of the Neurological Sciences|July 1, 1980
The process dynamics of viral and bacterial diseases of the central nervous systemK Felgenhauer, R Ackermann, G SchliepJournal of Neuroimmunology|November 1, 1991
Immunoblot for densitometric estimation of antibodies (IDEA): a useful method for quantification of intrathecally produced antibodies against individual antigens in infectious diseases of the central nervous systemB Neumann, K Ritter, K FelgenhauerEuropean Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies|August 1, 1991
A cationic glycoprotein pattern in human serum and cerebrospinal fluid with pathological implicationsM Mäder, K Retzlaff, K FelgenhauerPageof 23